Background Microalbuminuria in diabetes is strongly predictive of nephropathy, end-stage renal disease, and premature cardiovascular morbidity and mortality. Effective preventive therapies are therefore a clinical priority.Objective To determine whether the angiotensin-receptor blocker candesartan c...
No comments yet
Be the first to share your thoughts!